3
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Emerging Role of the Human Herpesvirus 8 (HHV8) in Human Neoplasia

Pages 461-468 | Published online: 06 Jul 2009

  • Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266(5192): 1865-9.
  • Antman K, Chang Y. Kaposi's sarcoma. New Engl J Med 2000; 342: 1027-38.
  • Moore PS. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). New Engl J Med 2000; 343: 1411-3.
  • Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. New Engl J Med 1998; 338: 948-54.
  • Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and highrisk HIV-seronegative women. / Am Med Assoc 1997; 277: 478-81.
  • Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcomaassociated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918-24.
  • Pauk J, Huang ML, Brodie SJ, et al Mucosal shedding of human herpesvirus 8 in men. New Engl J Med 2000; 343: 1369-77.
  • Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. New Engl J Med 2000; 343: 1378-85.
  • Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcomaassociated herpesvirus infection prior to onset of Kaposi's sarcoma. Aids 1996; 10: 175-80.
  • Whitby D, Howard MR, Tenant-Flowers M, et al Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIVinfected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346(8978): 799-802.
  • Katano H, Sata T, Suda T, et ci. Expression and antigenicity of human herpesvirus 8 encoded ORFS9 protein in AIDS-associated Kaposi's sarcoma. J Med Virol 1999; 59: 346-55.
  • Katano H, Sato Y, Kurata T, Mori S, Sata T. High expression of HHV8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 1999; 155: 47-52.
  • Sturzl M, Wunderlich A, Ascherl G, et al. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia 1999; 13(Suppl 1): S110-2.
  • Said JW, Chien K, Tasaka T, Koeffler HP. Ultrastructural characterization of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Kaposi's sarcoma lesions: electron microscopy permits distinction from cytomegalovirus (CMV). J Pathol 1997; 182: 273-81.
  • Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 1996; 70: 549-58.
  • Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248: 171-83.
  • Lee H, Veazey R, Williams K, et al Deregulation of cell growth by the Kl gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 1998; 4: 435-40.
  • Russo JJ, Bohenzky RA, Chien MC, et al Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862-7.
  • Sarid R, Wiezorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 1999; 73: 1438-46.
  • Jayachandra S, Low KG, Thlick AE, et al. Three unrelated viral transforming proteins (vIRF, EBNA2, and ElA) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptcrs. Proc Natl Acad Sci USA 1999; 96: 11566-71.
  • Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the Interferon signaling pathway. Oncogene 1997; 15: 1979-85.
  • Chang Y, Moore PS, Talbot SJ, et ai Cyclin encoded by KS herpesvirus. Nature 1996; 382(6590): 410.
  • LiM, Lee H, Yoon DW, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol 1997; 71: 1984-91.
  • Godden-Kent D, Talbot SJ, Boshoff C, et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone Hl. J Virol 1997; 71 : 4193-8.
  • Cheng EH, Nicholas J, Bellows DS, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bale. Proc Natl Acad Sci USA 1997; 94: 690-4.
  • Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997; 3: 293-8.
  • Friborg J Jr, Kong W, Hottiger MO, Nabel GJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999; 402(6764): 889-94.
  • Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000; 2: 819-25.
  • Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001; 75: 429-38.
  • Sturzl M, Hohenadl C, Zietz C, et al Expression of K13/V-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1999; 91: 1725-33.
  • Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998; 391(6662): 86-9.
  • Thome M, Schneider P, Hofmann K, et al Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386(6624): 517-21.
  • Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996; 274(5293): 1739-44.
  • Stine JT, Wood C, Hill M, et al KSHV-encoded CC chemolne vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 2000; 95: 1151-7.
  • Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gpl30 receptor subunit. J Biol Chem 1997; 272: 19625-31.
  • Ensoli B, Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 1998; 9: 63-83.
  • Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996; 93: 6641-6.
  • Miles SA. Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 1994; 6: 497-502.
  • Levine AM. AIDS-related malignancies: the emerging epidemic. J Natl Camer Inst 1993; 85: 1382-97.
  • Brenner B, Rakowsky E, Katz A. Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol 1999; 14: 1097-102.
  • Kennedy M, Biddolph S, Lucas S, et al. Cyclin Dl expression and HHV8 in Kaposi sarcoma. J Clin Pathol 1999; 52: 569-73.
  • Chor PJ, Santa Cruz DJ. Kaposi's sarcoma: A clinicopathologic review and differential diagnosis. J Cutan Pathol 1992; 19: 6-20.
  • Blauvelt A. The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma. Adv Dermatol 1999; 14: 167-206, discussion 207.
  • Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. New Engl J Med 1995; 332: 1181-5.
  • Sitas F, Newton R. Kaposi's sarcoma in south africa. J Natl Cancer Inst Monogr 2001; 28: 1-4.
  • Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 2000; 37: 1251-69.
  • Aoki Y, Jaffe ES, Chang Y, et al Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999; 93: 4034-43.
  • Ascoli V, Scalzo CC, Andreoni M, Manente L, Pistilli A, Lo Coco F. Kaposi's sarcoma following malignant mesothelioma. Virchows Arch 1999; 435: 612-5.
  • Boshoff C, Endo Y, Collins PD, et al Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997; 278(5336): 290-4.
  • Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 1999; 274: 21569-74.
  • Benelli R, Barbero A, Buffa A, et al Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. Int J Oncol 2000; 17: 75-81.
  • Luttichau HR, Lewis IC, Gerstoft J, Schwartz TW. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCRlO receptor. Eur J Immunol 2001; 31: 1217-20.
  • Luttichau HR, Stine J, Boesen TP, et al A highly selective CC chemokine receptor (CCR)S antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med 2000; 191: 171-80.
  • Fernandez-Figueras MT, Puig L, Penin RM, Mate JL, Bigata X, Ariza A. Decreased immunoreactivity for cell-cycle regulator p27(Kipl) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement. J Pathol 2000; 191: 387-93.
  • Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997; 390(6656): 184-7.
  • Gupta AK, Ruvolo V, Patterson C, Swaminathan S. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J Virol 2000; 74: 1038-44.
  • Mesri EA. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: a missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Blood 1999; 93: 4031-3.
  • Gomez-Roman JJ, Ocejo-Vmyals G, Sanchez-Velasco P, Nieto EH, Leyva-Cobian F, Val-Bemal JF. Presence of human herpesvirus-8 DNA sequences and overexpression of human IL-6 and cyclin Dl in inflammatory myofibroblastic tumor (inflammatory pseudotumor). Lab Invest 2000; 80: 1121-6.
  • Gomez-Roman JJ, Sanchez-Velasco P, Ocejo-Vinyals G, HernandezNieto E, Leyva-Cobian F, Val-Bemal JF. Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). Am J Surg Pathol 2001; 25: 624-9.
  • McDonagh DP, Liu J, Gaffey MI, Layfield LJ, Azumi N, Traweek ST. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am J Pathol 1996; 149: 1363-8.
  • Ishak KG, Bijwaard KE, Makhlouf HR, Taubenberger JK, Lichy JH, Goodman ZD. Absence of human herpesvirus 8 DNA sequences in vascular tumors of the liver. Liver 1998; 18: 124-7.
  • Kang GH, Kwon GY, Kim CW. Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors. J Korean Mod Sei 1998; 13:54-9.
  • Lasota J, Miettinen M. Absence of Kaposi's sarcoma-associated virus (human herpesvirus-8) sequences in angiosarcoma. Virchows Arch 1999; 434: 51-6.
  • Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New Engl J Med 1995; 332: 1186-91.
  • Carbone A, Gloghim A, Vaccher E, et al. Kaposi's sarcomaassociated herpesvirus DNA sequences in AIDS-related and AIDSunrelated lymphomatous effusions. Br J Haematol 1996; 94: 533-43.
  • Strauchen JA, Hauser AD, Burstein D, limenez R, Moore PS, Chang Y. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med 1996; 125: 822-5.
  • Nador RG, Cesarman E, Knowles DM, Said JW. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. New Engl J Med 1995; 333: 943.
  • Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, DallaFavera R. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 1996; 10: 1237-40.
  • Schulz TF. KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur J Cancer 2000; 37: 1217-26.
  • Carbone A, Cilia AM, Gloghini A, et al. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Br J Haematol 1998; 102: 1081-9.
  • Said JW, Shintaku IP, Asou H, et al. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Pathol Lab Med 1999; 123: 257-60.
  • Cannon JS, Nicholas J, Orenstein JM, et at. Heterogeneity of viral IL6 expression in HHV-8-associated diseases. J Infect Dis 1999; 180: 824-8.
  • Kuwabara H, Nagai M, Shibanusrri T, Ohmcri M, Kawakami K, Asakura H. CD138-positive and Kaposi's sarcoma-associated herpesvirus (KSHV)-negative B-cell lymphoma with serosal spreading of the body cavity and lymphadenopathy: an autopsy case. Hum Pathol 2000; 31: 1171-5.
  • Tanaka S, Katano H, Tsukamoto K, et al HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 2001; 51: 293-300.
  • Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-I and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995; 86: 2708-14.
  • Said JW, Tasaka T, Takeuchi S, et at Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virusassociated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124-8.
  • Hoischen SH, Vollmer P, Marz P, et al. Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells. Eur J Btochem 2000; 267: 3604-12.
  • Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 2000; 96: 1599-601.
  • Aoki Y, Tosato G, Nambu Y, Iwamoto A, Yarchoan R. Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas. Blood 2000; 95: 1109-10.
  • Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpes virus-associated infected primary effusion lymphoma cells. Blood 1999; 94: 2871-9.
  • Carbone A, Cilia AM, Gloghini A, et al. Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma. Leukemia 2000; 14: 1301-9.
  • Carbone A, Gloghini A, Bontempo D, et al. Proliferation in HHV8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kipl). Am J Pathol 2000; 156: 1209-15.
  • Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcomaassociated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826-9.
  • Parravinci C, Corbellino M, Paulli M, et al. Expression of a virusderived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997; 151: 1517-22.
  • Soulier J, Grollet L, Oksenhendler E, et al Kaposi's sarcomaassociated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
  • Corbellino M, Poirel L, Aubin JT, et al The role of human heipesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease). Clin Infect Dis 1996; 22: 1120-1.
  • Dupin N, Diss TL, Kellam P, et al HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV8-positive plasmablastic lymphoma. Blood 2000; 95: 1406-12.
  • Gessain A, Sudaka A, Briere J, et al Kaposi sarcoma-associated herpes-like virus (human heipesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 1996; 87: 414-6.
  • Matsushima AY, Strauchen JA, Lee G, et al Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 1999; 23: 1393-400.
  • Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human heipesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 2000; 96: 2069-73.
  • Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 1999; 96: 4546-51.
  • Parravicini C, Chandran B, Corbellino M, et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirusinfected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 2000; 156: 743-9.
  • Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human heipesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 2000; 269: 335-44.
  • Cannon JS, Ciufo D, Hawkins AL, et al A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 2000; 74: 10187-93.
  • Rettig MB, Ma HJ, Vescio RA, et al Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276(5320): 1851-4.
  • Samson D. Paraproteinaemias: pathophysiology. Schweiz Meet Wochenschr 2000; 130: 1643-8.
  • Tarte K, Chang Y, Klein B. Kaposi's sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood 1999; 93: 3159-63, discussion 3163-4.
  • Tarte K, Olsen SJ, Rossi JF, et al Kaposi's sarcoma-associated herpesvirus is not detected with immunosuppression in multiple myeloma. Blood 1998; 92: 2186-8.
  • Tarte K, Olsen SJ, Yang Lu Z, et al Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus. Blood 1998; 91: 1852-7.
  • Tedeschi R, Kvarnung M, Knekt P, er al. A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma. Br J Cancer 2001; 84: 122-5.
  • Cohen JD, Thomas E, Garnier N, et al [Association of Kaposi sarcoma -- multiple myeloma. A new case.] Rev Med Interne 2000; 21: 998-1000.
  • Goyal A, Langer JC, Zutter M, et al. Primary gastric plasmacytoma: a rare cause of hypertrophie gastritis in an adolescent. J Pediatr Gastroenterol Nutr 1999; 29: 424-30.
  • Olsen SJ, Tarte K, Sherman W, et al Evidence against KSHV infection in the pathogenesis of multiple myeloma. Virus Res 1998; 57: 197-202.
  • Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn 2001; 3: 32-8.
  • Le Gars L, Agbalika F, Picard O, Kaplan G, Berenbaum F. HHV8 status in Kaposi's sarcoma associated with multiple myeloma. Rev Rhum Engl Ed 1998; 65: 788-90.
  • DePond W, Said JW, Tasaka T, et al Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. fan J Surg Pathol 1997; 21: 719-24.
  • Lazzi S, Ferrari F, Nyongo A, et al HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998; 29: 1285-9.
  • Katano H, Suda T, Morishita Y, et al Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology. Mod Pathol 2000; 13: 77-85.
  • Allory Y, Challine D, Haioun C, et al Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western Institution. Am J Surg Pathol 2001; 25: 865-74.
  • Bates I, Bedu-Addo G, Jarrett RF, et al. B-lymphotropic viruses in a novel tropical splenic lymphoma. Br J Haematol 2001; 112: 161-6.
  • Brown RS, Power DA, Spittle HF, Lankester KJ. Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol (R Coll Radial) 2000; 12: 194.
  • Thomas JA, Brookes LA, McGowan I, Weller I, Crawford DH. HHV8 DNA in normal gastrointestinal mucosa from HIV seropositive people. Lancet 1996; 347(9011): 1337-8.
  • Strohal R, Tschachler E, Breyer S, et al. Reactivation of Behcet's disease in the course of multicentric HHV8-positive Castleman's disease: long-term complete remission by a combined cherao/ radiation and interferon-alpha therapy regimen. Br J Haematol 1998; 103: 788-90.
  • Trovato R, Luppi M, Barozzi P, et al Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies. J Hum Virol 1999; 2: 38-44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.